Growth Metrics

Aptargroup (ATR) Equity Income (2011 - 2026)

Aptargroup (ATR) reported Equity Income of $714000.0 for Q1 2026, down 65.77% year-over-year from $2.1 million in Q1 2025, and down 42.93% on a QoQ basis from $1.3 million in Q4 2025.

Aptargroup (ATR) has 16 years of Equity Income data on file, last reported at $714000.0 in Q1 2026.

  • Quarterly Equity Income fell 65.77% year-over-year to $714000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (up 151.5% YoY) and the FY2025 annual result came in at $7.4 million, up 8397.7% from the prior year.
  • Equity Income fell to $714000.0 in Q1 2026 per ATR's latest filing, from $1.3 million in the prior quarter.
  • Across five years, Equity Income topped out at $2.3 million in Q2 2025 and bottomed at -$276000.0 in Q2 2022.
  • The 5-year median for Equity Income is $643000.0 (2023), against an average of $640411.8.
  • The widest annual swing landed in 2022, when Equity Income slumped 440.74%; it then jumped 2368.83% in 2025.
  • Tracing ATR's Equity Income over 5 years: stood at $651000.0 in 2022, then increased by 9.37% to $712000.0 in 2023, then plunged by 64.19% to $255000.0 in 2024, then surged by 390.59% to $1.3 million in 2025, then plunged by 42.93% to $714000.0 in 2026.
  • Per Business Quant, the three latest ATR Equity Income figures stand at $714000.0 (Q1 2026), $1.3 million (Q4 2025), and $1.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 1.72 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 3.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 714,000.00
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 714,000.00
Dec 31, 2025 1.25 Mn
Sep 30, 2025 1.75 Mn
Jun 30, 2025 2.31 Mn
Mar 31, 2025 2.09 Mn
Dec 31, 2024 255,000.00
Sep 30, 2024 -77,000.00
Jun 30, 2024 130,000.00
Mar 31, 2024 -221,000.00
Dec 31, 2023 712,000.00
Sep 30, 2023 1.00 Mn
Jun 30, 2023 643,000.00
Mar 31, 2023 -131,000.00
Dec 31, 2022 651,000.00
Sep 30, 2022 178,000.00
Jun 30, 2022 -276,000.00
Mar 31, 2022 -86,000.00
Dec 31, 2021 -187,000.00
Sep 30, 2021 -71,000.00
Jun 30, 2021 81,000.00
Mar 31, 2021 -515,000.00
Dec 31, 2020 -60,000.00
Sep 30, 2020 -256,000.00
Jun 30, 2020 -328,000.00
Mar 31, 2020 -799,000.00
Dec 31, 2019 -17,000.00
Sep 30, 2019 238,000.00
Jun 30, 2019 9,000.00
Mar 31, 2019 -95,000.00
Dec 31, 2018 -99,000.00
Sep 30, 2018 -45,000.00
Jun 30, 2018 -20,000.00
Mar 31, 2018 -65,000.00
Dec 31, 2017 -87,000.00
Sep 30, 2017 -72,000.00
Jun 30, 2017 -22,000.00
Mar 31, 2017 -48,000.00
Dec 31, 2016 -4,000.00
Sep 30, 2016 -15,000.00
Jun 30, 2016 -51,000.00
Mar 31, 2016 -121,000.00
Dec 31, 2015 17,000.00
Sep 30, 2015 -209,000.00
Jun 30, 2015 -407,000.00
Mar 31, 2015 -119,000.00
Dec 31, 2014 -49,000.00
Sep 30, 2014 -124,000.00
Jun 30, 2014 -198,000.00
Mar 31, 2014 -1.55 Mn
Dec 31, 2013 -274,000.00
Sep 30, 2013 -286,000.00
Jun 30, 2013 -61,000.00
Mar 31, 2013 -262,000.00
Dec 31, 2012 61,000.00
Sep 30, 2012 -229,000.00
Jun 30, 2012 -158,000.00
Mar 31, 2012 -131,000.00
Dec 31, 2011 -143,000.00
Sep 30, 2011 126,000.00